AstraZeneca PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC with three other
pharmaceutical manufacturers in Europe:
Novo Nordisk As
sales of 126.95 billion Danish Kroner [US$20.39 billion]
of which 85%
was Diabetes and obesity),
(37.37 billion Euros [US$44.65 billion]
of which 69%
was Pharmaceuticals), and
based in GERMANY
(17.53 billion Euros [US$20.95 billion]
of which 43%
was Life Science).
During the year ended December of 2020, sales at
AstraZeneca PLC were £20.59 billion (US$28.56 billion).
increase of 8.0%
versus 2019, when the company's sales were £19.06 billion.